Navigation Links
HealthSouth to Present at J.P. Morgan Healthcare Global High Yield & Leveraged Finance Conference
Date:1/26/2009

BIRMINGHAM, Ala., Jan. 26 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS) today announced it will participate in the J.P. Morgan Healthcare Global High Yield & Leveraged Finance Conference on Feb. 2-4, 2009, in Miami Beach, Fla.

HealthSouth Chief Financial Officer John Workman will be speaking on Tuesday, Feb. 3, at 8 a.m. EST. The presentation will be webcast live and may be accessed via the Investor Information section on the company's Web site at www.healthsouth.com.

About HealthSouth

HealthSouth is the nation's largest provider of inpatient rehabilitation services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves more than 250,000 patients annually through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellites, and home health agencies. HealthSouth strives to be the nation's preeminent provider of inpatient rehabilitation services and can be found on the Web at www.healthsouth.com.

    Media Contact
    Andy Brimmer, 205-410-2777
    Investor Relations Contact
    Mary Ann Arico, 205-969-6175
    maryann.arico@healthsouth.com

'/>"/>
SOURCE HealthSouth Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HealthSouth Announces Date of 2008 Fourth Quarter and Year-End Earnings Conference Call
2. HealthSouth Reports Results for Third Quarter Ended September 30, 2008
3. HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance
4. HealthSouth Announces Plans to Build New Hospital in Arizona
5. HealthSouth to Hold Investor Meeting November 10, 2008
6. HealthSouth Finalizes Acquisition of Rehabilitation Unit at Medical Center of Arlington
7. HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital
8. HealthSouth Appoints Mary Ann Arico as SVP - Investor Relations and Corporate Communications
9. HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington
10. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
11. HealthSouth to Present at the 2008 Citigroup Global Healthcare Conference and Jefferies 2nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... 22, 2017 , ... “To Walk Away”: a captivating and romantic sequel ... Koontz. “To Walk Away” is the creation of published author, Larry R. Sherman, a ... manuscripts in chemistry and religion, as well as four novels. , Though the ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Covert Awakening”: Walid’s spiritual ... published author, Julianne Hale, a consultant for the Intelligence Community. For more ... on the Near East region. Julianne has written hundreds of reports for ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... TopConsumerReviews.com recently ... to fight Fatigue . , As the stress of modern life continually makes ... the pace. Constant use of artificial stimulants can trap people in vicious high/low cycles ...
(Date:8/21/2017)... ... , ... PracticeMatch, a company that provides online resources , job ... practitioners like nurse practitioners and physician assistants , will conduct its ... year. The online career fairs will allow job seekers to connect with healthcare employers ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los ... plastic surgery fellows for academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz ... completed residency in Plastic and Reconstructive Surgery. The candidate will have the ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... E.I. Medical Imaging (EIMI) has partnered with ... design the worlds first ultrasound system to be used underwater ... habitat. In preparation for a piece produced by Icon ... Dr. Guttridge approached EIMI with the idea of an underwater ... sharks underwater. EIMI ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 The ... treat rare nervous system diseases, has concluded a worldwide license ... the drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing ... in a Phase 2 study conducted in Europe ... the United States ...
Breaking Medicine Technology: